Neuroleptic hyperprolactinemia medicamentous correction

The article discusses various aspects of the main approaches to the issue of correction of neuroleptic hyperprolactinemia. Based on the generalized scientific and practical experience, algorithms for corrective therapy with dopamine agonists - bromocriptine and cabergoline (Dostinex) are given. The...

Full description

Saved in:
Bibliographic Details
Main Authors: L. N. Gorobets, G. E. Mazo
Format: Article
Language:Russian
Published: Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation 2018-07-01
Series:Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева
Subjects:
Online Access:https://www.bekhterevreview.com/jour/article/view/82
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849693478051643392
author L. N. Gorobets
G. E. Mazo
author_facet L. N. Gorobets
G. E. Mazo
author_sort L. N. Gorobets
collection DOAJ
description The article discusses various aspects of the main approaches to the issue of correction of neuroleptic hyperprolactinemia. Based on the generalized scientific and practical experience, algorithms for corrective therapy with dopamine agonists - bromocriptine and cabergoline (Dostinex) are given. The data on indications and contraindications to prescribing therapy with these drugs are substantiated, as well as features of their side effects.
format Article
id doaj-art-45e17570f7734cb4af09b028dcee9eb5
institution DOAJ
issn 2313-7053
2713-055X
language Russian
publishDate 2018-07-01
publisher Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation
record_format Article
series Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева
spelling doaj-art-45e17570f7734cb4af09b028dcee9eb52025-08-20T03:20:23ZrusFederal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian FederationОбозрение психиатрии и медицинской психологии имени В.М. Бехтерева2313-70532713-055X2018-07-0102798582Neuroleptic hyperprolactinemia medicamentous correctionL. N. Gorobets0G. E. Mazo1Federal State Institution “Scientific Center of Psychiatry and Narcology named by V.P Serbsky” of Health Ministry of Russia - a branch of the Moscow Research Institute of PsychiatrySt. Petersburg V.M. Bekhterev Research Psychoneurological Institute; St. Petersburg State UniversityThe article discusses various aspects of the main approaches to the issue of correction of neuroleptic hyperprolactinemia. Based on the generalized scientific and practical experience, algorithms for corrective therapy with dopamine agonists - bromocriptine and cabergoline (Dostinex) are given. The data on indications and contraindications to prescribing therapy with these drugs are substantiated, as well as features of their side effects.https://www.bekhterevreview.com/jour/article/view/82гиперпролактинемияантипсихотическая терапиядостинексбромокриптинhyperprolactinemiaantipsychotic therapydostinexbromocriptine
spellingShingle L. N. Gorobets
G. E. Mazo
Neuroleptic hyperprolactinemia medicamentous correction
Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева
гиперпролактинемия
антипсихотическая терапия
достинекс
бромокриптин
hyperprolactinemia
antipsychotic therapy
dostinex
bromocriptine
title Neuroleptic hyperprolactinemia medicamentous correction
title_full Neuroleptic hyperprolactinemia medicamentous correction
title_fullStr Neuroleptic hyperprolactinemia medicamentous correction
title_full_unstemmed Neuroleptic hyperprolactinemia medicamentous correction
title_short Neuroleptic hyperprolactinemia medicamentous correction
title_sort neuroleptic hyperprolactinemia medicamentous correction
topic гиперпролактинемия
антипсихотическая терапия
достинекс
бромокриптин
hyperprolactinemia
antipsychotic therapy
dostinex
bromocriptine
url https://www.bekhterevreview.com/jour/article/view/82
work_keys_str_mv AT lngorobets neuroleptichyperprolactinemiamedicamentouscorrection
AT gemazo neuroleptichyperprolactinemiamedicamentouscorrection